Growth Metrics

Emergent BioSolutions (EBS) Short-term Investments (2017 - 2026)

Emergent BioSolutions has reported Short-term Investments over the past 11 years, most recently at $1.2 million for Q1 2026.

  • For Q1 2026, Short-term Investments fell 67.57% year-over-year to $1.2 million; the TTM value through Mar 2026 reached $1.2 million, down 67.57%, while the annual FY2025 figure was $3.7 million, 39.34% down from the prior year.
  • Short-term Investments for Q1 2026 was $1.2 million at Emergent BioSolutions, down from $3.7 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $6.5 million in Q3 2024 and troughed at $100000.0 in Q3 2022.
  • A 4-year average of $2.6 million and a median of $2.5 million in 2024 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: soared 640.0% in 2025 and later crashed 67.57% in 2026.
  • Year by year, Short-term Investments stood at $100000.0 in 2022, then surged by 6000.0% to $6.1 million in 2024, then crashed by 39.34% to $3.7 million in 2025, then crashed by 67.57% to $1.2 million in 2026.
  • Business Quant data shows Short-term Investments for EBS at $1.2 million in Q1 2026, $3.7 million in Q4 2025, and $3.7 million in Q3 2025.